Haematological Abnormalities in Early Abstinent Alcoholics Are Closely Associated with Alterations in Thrombopoietin and Erythropoietin Serum Profiles

Summary

Numerous reports exist on haematological pathology in alcoholism. However, no data are available regarding a potential involvement of haematopoietic growth factors in the recovery from alcohol-induced haematological abnormalities upon abstinence. Therefore, thrombopoietin (TPO) and erythropoietin (EPO) serum levels along with haematological and other routine laboratory parameters were closely followed in 14 thoroughly characterized male alcoholic patients over one to five months of controlled abstention from alcohol. Haematological changes in these early abstinent alcoholics consisted predominantly of (a) the well known rebound surge of platelets, (b) an early reticulocyte peak, and (c) persistently low haematocrit levels over months without signs of recovery. Observations on EPO and TPO during early abstinence can be summarized as follows: (1) Increased TPO levels precede the rebound thrombocytosis by several days, (2) both EPO and TPO concentrations are higher in anaemic than in nonanaemic alcoholics, with (3) nonanaemic subjects exhibiting levels of TPO in the range of healthy controls but levels of EPO below controls and (4) TPO concentrations show a stronger correlation with initial haematocrit values than with thrombocyte counts. To conclude, haematological recovery in early alcohol abstinence appears to be, at least in part, growth factor-driven, involving both TPO and EPO, and may reflect an intense interaction of erythro- and thrombopoiesis.

Keywords

Erythropoietin - thrombopoietin - alcoholism - abstinence - trombocytosis

• References

• 1 Colman N, Herbert V. Hematologic complications of alcoholism: overview. Semin Hematol 1980; 17: 164-76.
• 2 Ballard HS. Hematological complications of alcoholism. Alcohol Clin Exp Res 1989; 13: 706-20.
• 3 Michot F, Gut J. Alcohol-induced bone marrow damage. A bone marrow study in alcohol-dependent individuals. Acta Hematol 1987; 78: 252-7.
• 4 Sanft HJ, Schulz K. Hematologic changes following chronic alcoholism. Folia Haematol Int Mag Klin Morphol Blutforsch 1983; 110: 540-63.
• 5 Levine RF, Spivak JL, Meagher RC, Sieber F. Effect of ethanol on thrombopoiesis. Br J Haematol 1986; 62: 345-54.
• 6 Cowan DH. Effect of alcoholism on hemostasis. Semin Hematol 1980; 17: 137-47.
• 7 Haselager EM, Vreeken J. Rebound thrombocytosis after alcohol abuse: a possible factor in the pathogenesis of thromboembolic disease. Lancet 1977; 1: 774-5.
• 8 Renaud SC, Ruf JC. Effects of alcohol on platelet functions. Clin Chim Acta 1996; 246: 77-89.
• 9 Hillbom M, Kaste M. Alcohol abuse and brain infarction. Ann Med 1990; 22: 347-52.
• 10 Gorelick PB. Alcohol and stroke. Stroke 1987; 18: 268-71.
• 11 Odell TTJ, McDonalds PP, Detwiler TC. Stimulation of platelet production by serum of platelet-depleted rat. Proc Soc Exp Biol Med 1961; 108: 428-31.
• 12 de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang WJ, Oles KJ, Hultgren B, Solberg LA, Goeddel DV, Eaton DL. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994; 369: 533-8.
• 13 Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, Grant FJ, Heipel MD, Burkhead SK, Kramer JM, Bell LA, Sprecher CA, Blumberg H, Johnson R, Prunkard D, Ching AF, Mathewes SL, Bailey MC, Forstrom JW, Buddle MM, Osborn SG, Evans SJ, Sheppard PO, Presnell SR, O’Hara PJ, Hagen FS, Roth GJ, Foster DC. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994; 369: 565-8.
• 14 Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chang MS, Samal B, Nichol JL, Swift S, JJM Hsu RY, Parker VP, Suggs S, Skrine JD, Merewether LA, Clogston C, Hsu E, Hokom MM, Hornkohl A, Choi E, Pangelinian M, Sun Y, Mar V, McNinch J, Simonet L, Jacobsen F, Xie C, Shutter J, Chute H, Basu R, Selander L, Trollinger D, Sieu L, Padilla D, Trail G, Eliott G, Izumi R, Covey T, Crouse J, Garcia A, Xu W, Del Castillo J, Biron J, Cole S, Hu MC-T, Pacifici R, Ponting I, Saris C, Wen D, Yung YP, Lin H, Bosselman RA. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994; 77: 1117-24.
• 15 Sohma Y, Akahori H, Seki N, Hori T, Ogami K, Kato T, Shimada Y, Kawamura K, Miyazaki H. Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Lett 1994; 353: 57-61.
• 16 Kuter DJ, Beeler DL, Rosenberg RD. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci USA 1994; 91: 11104-8.
• 17 Eaton DL, de Sauvage FJ. Thrombopoietin: the primary regulator of megakaryocytopoiesis and thrombopoiesis. Exp Hematol 1997; 25: 1-7.
• 18 Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 1995; 86: 419-31.
• 19 Kaushansky K, Broudy VC, Grossmann A, Humes J, Lin N, Ren HP, Bailey MC, Papayannopoulou T, Forstrom JW, Sprugel KH. Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy. J Clin Invest 1995; 96: 1683-7.
• 20 Erslev AJ. Erythropoietin. N Engl J Med 1991; 324: 1339-44.
• 21 Broudy VC, Lin NL, Kaushansky K. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 1995; 85: 1719-26.
• 22 Emmons RV, Reid DM, Cohen RL, Meng G, Young NS, Dunbar CE, Shulman NR. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 1996; 87: 4068-71.
• 23 Ehrenreich H, Mangholz A, Schmitt M, Lieder P, Volkel W, Ruther E, Poser W. OLITA: an alternative in the treatment of therapy-resistant chronic alcoholics. First evaluation of a new approach. Eur Arch Psychiatry Clin Neurosci 1997; 247: 51-4.
• 24 Marsh JC, Gibson FM, Prue RL, Bowen A, Dunn VT, Hornkohl AC, Nichol JL, Gordon-Smith EC. Serum thrombopoietin levels in patients with aplastic anaemia. Br J Haematol 1996; 95: 605-10.
• 25 O’Brien PC. Procedures for comparing samples with multiple endpoints. Biometrics 1984; 40: 1079-87.
• 26 Ulich TR, del Castillo J, Senaldi G, Kinstler O, Yin S, Kaufman S, Tarpley J, Choi E, Kirley T, Hunt P, Sheridan WP. Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice. Blood 1996; 87: 5006-15.
• 27 Kosugi S, Kurata Y, Tomiyama Y, Tahara T, Kato T, Tadokoro S, Shiraga M, Honda S, Kanakura Y, Matsuzawa Y. Circulating thrombopoietin level in chronic immune thrombocytopenic purpura. Br J Heaematol 1996; 93: 704-6.
• 28 Cowan DH. Thrombokinetic studies in alcohol-related thrombocytopenia. J Lab Clin Med 1973; 81: 64-76.
• 29 Toghill PJ, Green S. Platelet dynamics in chronic liver disease using the 111Indium oxine label. Gut 1983; 24: 49-52.
• 30 Sungaran R, Markovic B, Chong BH. Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood 1997; 89: 101-7.
• 31 Gleiter CH, Brause M, Delabar U, Zebski H, Eckardt KU. Evidence against a major role of adenosine in oxygen-dependent regulation of erythropoietin in rats. Kidney Int 1997; 52: 338-44.
• 32 Danielson B. R-HuEPO hyporesponsiveness – who and why?. Nephrol Dial Transplant 1995; 10: 69-73.
• 33 Means RT, Mendenhall CL, Worden BD, Moritz TE, Chedid A. Erythropoietin and cytokine levels in the anemia of severe alcoholic liver disease. Alcohol Clin Exp Res 1996; 20: 355-8.
• 34 Baer AN, Dessypris EN, Goldwasser E, Krantz SB. Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol 1987; 66: 559-64.
• 35 Miller CB, Jones RJ, Piantadosi S, Abeloff MD, Spivak JL. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 1990; 322: 1689-92.
• 36 Khoruts A, Stahnke L, McClain CJ, Logan C, Allen JI. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991; 13: 267-76.
• 37 Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992; 79: 1987-94.
• 38 Abbrecht PH, Littell JK. Plasma erythropoietin in men and mice during acclimatization to different altitudes. J Appl Physiol 1972; 32: 54-8.
• 39 Cahan C, Hoekje PL, Goldwasser E, Decker MJ, Strohl KP. Assessing the characteristic between length of hypoxic exposure and serum erythropoietin levels. Am J Physiol 1990; 258: R1016-21.
• 40 Giglio MJ, Santoro RC, Bozzini CE. Effect of chronic ethanol administration on production of and response to erythropoietin in the mouse. Alcohol Clin Exp Res 1984; 8: 323-5.
• 41 Halmesmaki E, Teramo KA, Widness JA, Clemons GK, Ylikorkala O. Maternal alcohol abuse is associated with elevated fetal erythropoietin levels. Obstet Gynecol 1990; 76: 219-22.
• 42 Casagrande G, Michot F. Alcohol-induced bone marrow damage: status before and after a 4-week period of abstinence from alcohol with or without disulfiram. A randomized bone marrow study in alcohol-dependent individuals. Blut 1989; 59: 231-6.
• 43 Ehrenreich H, tom Dieck K, Gefeller O, Kaw S, Schilling L, Poser W, Ruther E. Sustained elevation of vasopressin plasma levels in healthy young men, but not in abstinent alcoholics, upon expectation of novelty. Psychoneuroendocrinology 1997; 22: 13-24.